10 Most Promising Healthcare Stocks According to Wall Street Analysts
The US healthcare sector has trailed the broader market for three consecutive years, returning just 0.3% in 2023, 0.9% in 2024, and 12.5% in 2025.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 24,312,352 | $1,525,600,089 | +117% | 0.92% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 13,891,668 | $871,702,167 | +26% | 0.47% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 9,411,231 | $590,554,745 | +50% | 0.48% |
| 4. | Farallon Capital Thomas Steyer | 7,470,684 | $468,785,421 | +1% | 2.67% |
| 5. | AQR Capital Management Cliff Asness | 5,239,836 | $327,280,182 | +378% | 0.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.49 | 1,770 | $99,987.30 | 1,770 | 2026-05-20 | Filing | |
| $56.68 | 3,580 | $202,914.40 | 25,359 | 2026-05-20 | Filing | |
| $55.92 | 2,250 | $125,818.88 | 13,878 | 2026-05-20 | Filing | |
| $56.95 | 2,200 | $125,279.22 | 11,628 | 2026-05-19 | Filing | |
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $93.49 | 159,701 | $14,930,526.34 | 1,411,735 | 2026-02-02 | Filing | |
| $94.06 | 1,200 | $112,868.04 | 1,571,436 | 2026-02-02 | Filing | |
| $101.55 | 17,313 | $1,758,188.82 | 23,600 | 2025-12-01 | Filing | |
| $98.28 | 12,891 | $1,266,977.75 | 24,134 | 2025-11-06 | Filing | |
| $99.14 | 29,472 | $2,921,895.34 | 178,342 | 2025-11-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 131,822,037 | $8,271,832,842 | 0.14% | |
| 2. | 96,411,568 | $6,049,825,893 | 0.14% | |
| 3. | 74,226,395 | $4,657,706,307 | 0.25% | |
| 4. | 67,986,847 | $4,266,174,649 | 0.15% | |
| 5. | 33,350,157 | $2,098,725,515 | 0.13% |
News See All
Below Expected Outlook Pressured Boston Scientific (BSX) in Q1
Renaissance Investment Management, an investment management company, released its Q1 2026 “Large Cap Growth Strategy.” A copy of the letter can be downloaded here.
12 Best Buy-the-Dip Stocks to Invest In Now
In this article, we will take a look at some of the best buy-the-dip stocks that are currently offering attractive upside potential. On June 5, CNBC reported that U.S.
Billionaire Lee Ainslie's 10 Stocks with Huge Upside Potential
There is more greed than fear, going by the blockbuster gains in the equity markets following the US-Iran war-triggered correction in March.
Top 10 Lowest P/E Ratio Stocks of the S&P 500
Valuations in the S&P 500 have rarely offered this much debate.
Is Boston Scientific (BSX) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential?
Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare stocks to buy with highest upside potential. TD Cowen cut the price target on Boston Scientific Corporation (NYSE:BSX) to $61 from...
10 Best Healthcare Stocks to Buy with Highest Upside Potential
On June 1, Tom Lee, Fundstrat managing partner and head of research, and Fundstrat Capital CIO, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends, the market outlook, and more...
Is Boston Scientific Corporation (BSX) One of the Top Cheap Stocks With Strong Buy Ratings on Wall Street?
Boston Scientific Corporation (NYSE:BSX) is one of top cheap stocks with Strong Buy ratings on Wall Street. Boston Scientific Corporation (NYSE:BSX) received a rating update from Canaccord on June 1.
Top 10 Cheap Stocks With Strong Buy Ratings on Wall Street
On June 1, Tom Lee, Fundstrat managing partner and head of research, and Fundstrat Capital CIO, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends, the market outlook, and more...
Wolfe Research Downgrades Boston Scientific Corporation (BSX) To Peer Perform
This marks the end of the firm’s bullish outlook on the stock for four years, with the adjustment coming after the company said sales growth of its Watchman implant, which reduces the risk of stroke...
Hedge Fund Resource Center